have supported the view that many of the palisading cells are monocytes, as they are usually HLA-DR and CDllb (OKM 1) positive.6 ' Many of the cells in the granulomatous area seem to be T cells.6 8 However, it is still debatable whether the palisading cells may be fibroblasts, and whether vasculitis occurs in the granulomatous tissue.192 This study looked for evidence of complement activation in the granulomatous tissue with a monoclonal antibody to a C9 neoepitope appearing during the activation of the terminal complement pathway. 3 In addition, the palisading cells were examined with a new set of monoclonal antibodies to obtain more precise information about their origin. 4 Materials and methods To obtain a strong signal for the detection of T cells a mixture of antibodies for CD3 and CD5 was used. When the existence of CD5 positive B cells was reported in normal subjects and patients with rheumatoid arthritis,'5 ten The specificity of the antisera and antibodies was examined by testing the performance on selected tissues known to contain the antigens. For the antisera to immunoglobulins and fibrinogen the specificity was further tested by blocking experiments performed with purified antigens. The specificity of the various antibodies to membrane antigens was also tested on mononuclear cells isolated from peripheral blood. Controls with FITC labelled rabbit antimouse immunoglobulin alone were included for each biopsy sample and were consistently negative. Control experiments were also performed with FITC labelled rabbit antimouse immunoglobulin after incubation with normal mouse IgG at concentrations which should contain the immunoglobulin subclasses in amounts corresponding to those in the specific monoclonal antibodies. These control experiments were also always negative.
For each biopsy sample one section was stained conventionally with haematoxylin and eosin. This section was examined first to determine whether the tissue was representative with a clearly identifiable nodular structure. If this was not so new sections were cut until representative areas were obtained. In three of the eight nodules, representative areas were not found and these nodules were not studied further.
The immunofluorescence microscopic examinations were performed with a Leitz Orthoplan incident light microscope. The mean number of cells with positive immunofluorescence counted in five 0-1 mm2 areas was recorded according to the following scale: 0=no positive cells observed; 1=positive cells observed, but less than one per 0-1 mm2; 2=average of one to ten positive cells per 0-1 mm2; 3=average of 11-100 positive cells per 0-1 mm2; and 4=average of >100 positive cells per 0-1 mm2. For quantification of extracellular deposits an arbitrary grading from 0 to 4 was used.
Results

CHARACTERISATION OF MONONUCLEAR CELLS
No cells were found which reacted with antibodies to IgG or IgA, whereas antibodies to IgM reacted with cytoplasma in a few cells which Immunopathology ofsubcutaneous rheumatoid nodules to DR (fig IB) . With IgM RFD1, no cells were stained in the palisading cell area, whereas in two of the five nodules, scattered positive cells were seen in the granulomatous area. The RFD1 antibody is directed against interdigitating cells, macrophage related cells which may be identical to dendritic cells. Thus the number of cells of this type was considerably lower than that of the macrophages.
With the mixture of the two antibodies to T cells, a large number of T cells were found in the granulomatous area in all patients, especially around small vessels. Only a few positive cells were found in the area of palisading cells.
EXTRACELLULAR DEPOSITS
There was weak and diffuse immunofluorescence in the necrotic area and no fluorescence in the palisading area when antisera to the immunoglobulin classes were used (table 3). The granulomatous area was also negative, except for one nodule in which there was a weak granular fluorescence with antibodies to IgM in scattered vessel walls. Deposits of complement were looked for by two antibodies, one directed against C3c, reacting both with native and activated C3. A weak and diffuse fluorescence was observed in the necrotic area and no fluorescence was seen in the palisading area using this antibody. In the peripheral granulomatous area there was granular fluorescence in the walls of small vessels in all nodules (fig 2A) . A weaker granular fluorescence was obtained with a monoclonal antibody to the terminal complement complex, CSb-9, reacting with a neoepitope in C9 which is revealed during activation ( fig 2B) . With Signs of vasculitis are not uncommon in extra-articular tissues in rheumatoid arthritis. The development of rheumatoid nodules on sites which are often subjected to external pressure may thus be the result of a combination of a general immunological process in the vessel walls and a local mechanical factor from the external pressure. Alternatively, the immunological process may, as recently suggested by Ziff,"8 be local and secondary to damage to small blood vessels. 
